Sun Pharmaceutical Industries Ltd. 524715 shares inched up 0.20% to 1,642.90 Indian rupees Friday, on what proved to be an ...

At the current price, shares of Sun Pharma are trading at a financial year 2027 price-to-earnings multiple of 32 times, which ...

Discover the Sun Pharma Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

BoFA values the stock at 32 times FY27 earnings against its 10-year average of 25.5 times, reflecting its transition to ...

With the stock currently trading at Rs 1,618.70, Sun Pharmaceutical Industries reflects a bearish trend amid overall positive financial performance and active corporate actions.

Sun Pharmaceutical shares dropped by 2.8% after Bank of America downgraded the stock due to concerns over premium valuations and slower speciality execution.

Indian benchmark indices Sensex and Nifty ended lower on Tuesday, after the United States issued a draft notice to impose ...

Bank of America downgraded Sun Pharma stock to ‘underperform’ from ‘neutral’, citing risks to premium valuations and slower ...

Sun Pharmaceutical Industries' shares fell by 2.29% to Rs 1,618.70 during Tuesday's early trading, despite consistent financial growth over recent years.

In Nifty Realty, Godrej Properties, Lodha, and DLF led losses by nearly 2% each. Nifty Pharma was trading at 22,082.55, lower ...

Indian stock market indices Sensex and Nifty plunged significantly due to concerns over US tariffs and foreign fund outflows, ...

Shares of Sun Pharma declined 2.61% to Rs 1,613.40 in Tuesday's session, making it one of the top losers on the Nifty 50. Other top losers on Nifty 50 included Shriram Finance, Tata Steel, Dr Reddys ...